Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites

Hepatology

Volumn 31, Issue 2, 2000, Pages 304-310

  Angeli, Paolo ^a,d   Jiménez, Wladimiro ^b   Veggian, Rosalia ^a   Fasolaio, Silvano ^a   Volpin, Roberta ^a   Machenzie, Harald S ^c   Craighero, Raffaella ^a   Libera, Virna Dalla ^a   Sticca, Antonietta ^a   Arrovo, Vicente ^b   Gatta, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b HOSPITAL CLÍNIC   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Dept of Clin and Exp Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP PHOSPHODIESTERASE; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; LIVER CIRRHOSIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SODIUM EXCRETION;

EID: 17544381822     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310207     Document Type: Article

References (14)

1. Jamison RL, Canaan-Kühl S, Pratt R. The natriuretic peptides and their receptors. Am J Kidney Dis 1992;20:519-530.
2. Flynn TG, deBold MI, deBold AJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983;117:859-865.
3. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ongawa Y, Shirakami G, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991;87:1402-1412.
4. Sudoth T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP); a new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-870.
5. Schulz-Knappe P, Forssmann K, Herbest F, Hick D, Pipkorn R, Forssmann WG. Isolation and structural analysis of "urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Whochenschr 1988;66:752-759.
6. Gerbes AL, Arendt RM, Ritter D, Jungst D, Zahringer J, Paumgartner G. Plasma atrial natriuretic factor in patients with cirrhosis. N Engl J Med 1985;313:1609-1610.
7. Ginès P, Jiménez W, Arroyo V, Navasa M, Lopez C, Tito L, Serra A, et al. Atrial natriuretic factor in cirrhosis with ascites; plasma levels, cardiac release and splanchnic extraction. HEPATOLOGY 1988;8:636-642.
8. La Villa G, Romanelli RG, Casini Raggi V, Tosti Guerra C, De Feo ML, Marra F, Laffi G, et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. HEPATOLOGY 1992;16:156-161.
9. Salo J, Jiménez W, Kuhn M, Ginès A, Ginès P, Fernandez-Esparrach G, Angeli P, et al. Urinary excretion of urodilatin in patients with cirrhosis. HEPATOLOGY 1996;24:1428-1432.
10. Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel C, Gatta A. Variability of atrial natriuretic peptide in ascitic cirrhotics: pathophysiological and clinical implications. HEPATOLOGY 1992;16:1389-1394.
11. Jiménez W, GutkowskaJ, Ginés P, Arroyo V, Rivera F, Rodés J. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites. HEPATOLOGY 1991;14:601-607.
12. Angeli P, Jiménez W, Arroyo V, MacKenzie HS, Zhang PL, Claria J, et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. HEPATOLOGY 1994;20:948-954.
13. Salerno F, Badalamenti S, Incerti P, Capozza L, Mainardi L. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. HEPATOLOGY 1988;8:21-26.
14. Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, Cominelli F, et al. Renal haemodynamic and natriuretic effects of atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology 1989;96:167-177.